As Germany solidifies its position as one of Europe’s largest cannabis markets, three companies stand out as key players in domestic cultivation: Tilray Brands Inc. (NASDAQ:TLRY), Aurora Cannabis Inc. (NASDAQ:ACB) and Demecan. These companies are not only significant in terms of their cultivation capacity but also in their strategic positioning to capitalize on Germany’s growing medical cannabis market, which is projected to reach a valuation of approximately €1.7 billion ($1.86 billion) by 2025. Tilray BrandsTilray has been a leading force in Germany’s cannabis industry, operating through its…